About Us

Our team brings together extensive experience in drug discovery and development. With a proven track record of delivering best-in-class medicines, we combine deep disease biology expertise with cutting-edge technologies. The team has successfully advanced both small and large molecule programmes across various therapeutic areas

Backed by Leading Investors

Finchley Health Ventures
Luma Group
NH
Forbion
Sofinnova
Samsara Bio Capital
Balyasny